Back
TG Therapeutics Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
54
TGTX
TG Therapeutics
Last Price:
$34.50
Seasonality Move:
-2.26%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGTX is experiencing selling pressure, which indicates risk of future bearish movement.
TG Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.65 | Sell |
20-day SMA: | 39.09 | Sell |
50-day SMA: | 38.5 | Sell |
200-day SMA: | 29.89 | Buy |
8-day EMA: | 36.9 | Sell |
20-day EMA: | 38.41 | Sell |
50-day EMA: | 37.66 | Sell |
200-day EMA: | 30.87 | Buy |
TG Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 35.53 | Sell |
Chaikin Money Flow: | -1569329 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.22 - 41.88) | Sell |
Bollinger Bands (100): | (30.21 - 39.39) | Sell |
TG Therapeutics Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for TG Therapeutics Stock
Is TG Therapeutics Stock a Buy?
-
TG Therapeutics share price is 33.64 while TGTX 8-day simple moving average is 38.65, which is a Sell signal.
-
The stock price of TGTX is 33.64 while TG Therapeutics 20-day SMA is 39.09, which makes it a Sell.
-
TG Therapeutics 50-day simple moving average is 38.50 while TGTX share price is 33.64, making it a Sell technically.
-
TGTX stock price is 33.64 and TG Therapeutics 200-day simple moving average is 29.89, creating a Buy signal.
TGTX Technical Analysis vs Fundamental Analysis
Buy
54
TG Therapeutics (TGTX)
is a Buy
Is TG Therapeutics a Buy or a Sell?
-
TG Therapeutics stock is rated a BuyThe current TG Therapeutics [TGTX] share price is $33.64. The Score for TGTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
TG Therapeutics Stock Info
Market Cap:
5.3B
Price in USD:
33.64
Share Volume:
2.2M
TG Therapeutics 52-Week Range
52-Week High:
46.48
52-Week Low:
15.16
Buy
54
TG Therapeutics (TGTX)
is a Buy
TG Therapeutics Share Price Forecast
-
What is the TG Therapeutics stock price today?The TG Therapeutics stock price is 33.64 USD today.
-
Will TGTX stock go up or go down?TG Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is TG Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, TG Therapeutics is not overvalued.
Is TG Therapeutics Stock a Buy?
-
TG Therapeutics share price is 33.64 while TGTX 8-day exponential moving average is 36.90, which is a Sell signal.
-
The stock price of TGTX is 33.64 while TG Therapeutics 20-day EMA is 38.41, which makes it a Sell.
-
TG Therapeutics 50-day exponential moving average is 37.66 while TGTX share price is 33.64, making it a Sell technically.
-
TGTX stock price is 33.64 and TG Therapeutics 200-day simple moving average is 30.87, creating a Buy signal.
Fundamental Analysis of TG Therapeutics
Is TG Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.18 per share, an increase this year of $0.77 per share, and an increase next year of $0.85 per share.
Technical Analysis of TG Therapeutics
Should I short TG Therapeutics stock?
-
TGTX Moving Average Covergence Divergence (MACD) indicator is -0.65, suggesting TG Therapeutics is a Sell
-
TG Therapeutics Relative Strength Index (RSI) is 35.53, which suggest TG Therapeutics is oversold
-
The Bollinger Bands (25) for TG Therapeutics is (35.22 - 41.88), which suggest TG Therapeutics is a Sell
-
The Bollinger Bands (100) for TG Therapeutics is (30.21 - 39.39), which suggest TG Therapeutics is a Sell
* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.